|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,584.10 INR | +2.58% |
|
-0.11% | +11.24% |
| 06-01 | Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026 | |
| 05-29 | Ipca Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 980B | |||||
| 550B | |||||
| 382B | |||||
| 317B | |||||
| 270B |
Select your edition
All financial news and data tailored to specific country editions
